Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well - I think we might be seeing where those 2.3 million shares to change hands on monday due to the PUTS are coming from - scared shitless retail longs.
Don't believe anyone is trading on inside information as it would be a dead giveaway and they would be in a world of trouble.
I'm scared shitless - but I'm buying
he used to say this would one day be a $20 stock, so you have upped it to $30.
Right now for October expiration (next friday) there are only 83 calls that are in the money - representing 8,300 shares... practically meaningless.
However, there are ~ 23,000 puts that are in the money - representing 2,300,000... so, where are those shares coming from to put to the PUT sellers???
Company submitted an IND for Regabatin XR in August 2015.
at-the-market issuances of 218,300 of our common shares sold on NASDAQ for gross proceeds of $0.7 million
as per Della Penna - earnings released tomorrow - PRE market open.
I was afraid it was bad news and released at market close.
WOW - adds 3 months of life
Novocure bills $21,000 monthly for Optune
Novocure nabs first-line FDA approval for glioblastoma, turns to reimbursement and other solid tumors
October 6, 2015
WOW - adds 3 months of life
Novocure bills $21,000 monthly for Optune in the U.S. and commercial third-party payers and privately administered government plans
p.s. Seroquel XR is a $1.2 BILLION drug - 6 months exclusivity = $600 Million x 60% (40% discount over brand name) = $360 million x 25% market capture during 6 month exclusivity = $90 million x 50% (50/50 split with Teva - most likely) = $45 million divided by 25 million shares = $1.80 earnings per share for 6 months x 20 p/e (reasonable for growing concern) = $36.00 +/- 20% = ~ $28.80 to $43.20 fair value per share... just on Seroquel XR.
When Will the Generic Be Available?: Some or all forms of Seroquel XR may become available as generic quetiapine xr after November 2016, depending on FDA approval and patent expiration.
I believe IPCI was first to file and has 180 day exclusivity on all 5 strenghts, and I believe this is the drug that they have partnered with TEVA
viva Las Vegas!
It was stated here a while back that only Rexista/Podras was given fast track status...
NOT TRUE - according to Della Penna, Rexista/Podras AND Rexista/Classic have both been given Fast Track Status.
Retail has been large net sellers
Currently the company Insiders own 0.93% of IntelliPharmaCeutics International Inc. Company shares. In the past six months, there is a change of 0% in the total insider ownership. Institutional Investors own 0.5% of Company shares. During last 3 month period, -4.72% of total institutional ownership has changed in the company shares.
FDA Panel Unanimously Recommended Approval (23-0) of Collegium’s (COLL-NASDAQ) Xtampza: Xtampza is an extended release formulation of oxycodone that should be taken after eating to maximize effectiveness. The review committee has flagged food effects as a safety concern for potential addiction and abuse. The FDA’s concern is that if a patient takes Xtampza without eating, there may not be sufficient pain relief— which could lead the patient to overdose in an attempt to achieve sufficient relief. This product is expected to be approved but we believe IPCI has a better formulation as it should not have the same issues with fed or fasting, as well as other competitive advantages.
a panel of outside advisers to the FDA vote unanimously in favor of the drug.
"About Janacoco
www.inspire.com/Janacoco
38 years old, Female, Married
Garland, Texas
Joined January 13, 2012
My son, Aaron,
http://news.yahoo.com/fda-staff-says-errors-likely-administering-purdues-fast-130625775--finance.html
for what it's worth - A panel of outside advisers is scheduled to meet on Thursday to recommend whether the drug should be approved. The FDA is not obliged to follow the advice of its advisory panels but usually does.
$200M per year in Rexista rev's alone...making all 7 of IPCI's pending FDA ANDA approvals just extra gravy for the real coming meat on their best in class NDA's choo-choo;)
Yes Fabius... saw your post after I posted mine... but a "best in class" designation is well worth repeating.
By the way... has a meeting in Las Vegas been set up to celebrate IPCI's "coming out" party???
If so... at what price and who's in charge???
I suggest the buffet at Bellagio when IPCI hits $20.00
@IPCIPharma: http://buff.ly/1NtpjSa
Hard shells and antagonists might foil the casual recreational user, but they can be easily circumvented by drug dealers with a basic grasp of chemistry.
Another problem is that the current technologies focus on preventing tampering with the pill — crushing, chewing, dissolving. But more than 90% of opioid abuse is oral. Most users just take more pills than they should.
***more than 90% of opioid abuse is oral. Most users just take more pills than they should.***
That's what will make IPCI's technology "best in class"... taking more than one pill just negates the effect.
It's only a matter of time
CFO was just buying IPCI shares on the open market last month at 4.80 per share on the TSX
a $3.8 billion brand sales drug
Hopefully an upfront payment comes with it.
If it's for Seroquel which I believe was first to file on all strenghts, and is an $800 Million drug, I hope they get $20 million upfront
thanxs Doog
Penna bought another 45,000 shares on the open market on 07/21
Here is an interesting transaction that I noticed last wednesday - this was the day that IPCI spiked, and towards the end of the day it was trading at ~ $3.60ish
I was cruising for some deals in IPCI options, and noticed that someone had gotten $2.40 for Jan 2016 $5.00 PUTS. This effectively made his stock cost $2.60, not bad... $1.00 discount to the trading price... AND someone was asking 45 cents for Jan 2015 $5 CALLS.
A bell went off... and as I was putting in my Sell order for the PUTS I saw 18 more of them trade for $2.60 - my order for 100 PUTS was seconds behind it... and as I was writing up my order to buy $5 CALLS, I saw 18 of those trade for 45 cents - my order was seconds behind that for 200 CALL options.
So someone, in a small scale at least, pretty much did what I tried to do. Unfortunately stock was quickly going down and my trades never happened.
This was the strategy - I always work with the options leg of trades first, as stock is always more liquid.
The intent was to sell 100 $5 PUTS at $2.40 thereby effectively make the cost of my stock $2.60 if put to me - at the same time sell 10,000 shares of stock at $3.60 which it was trading at... then take the $1.00 difference and buy 200 Jan $5 CALLS (20,000 shares) at 45 cents each... the remaining 10 cents would more than cover commissions.
This would effectively produce the same results if stock was up to $5 by January... BUT if it went above $5.00 where my CALL options would kick in... my profit thereafter would be on 20K shares rather than the 10K shares I sold.
I don't know if whoever worked the 18 option trades sold the stock or not... may not have... good deal either way... but should have doubled up on the CALLS rather than pocket the 55 cents - it was free money anyway and I think >$5.00 is probable by January.
Here are details of what I did with the options, I researched what the stock price was when I did this - hopefully all can follow it.
Between Jan 14 and Jan 23, while IPCI stock was trading at ~ $2.25, I sold 447 July 2015 $7.50 PUT options (each option is 100 shares so = 44,700 shares) for an average of $5.60 per share ($5.601066 exactly).
That is, I gave "someone" the right to PUT to me between January xx and July 17, 2015 IPCI shares at a price of $7.50 per share and that "someone" paid me up front $5.60 per share for that right.
This effectively made my cost for each share $1.90 if PUT to me... or 35 cent discount to the trading price of $2.25 at that time.
So the value of the 44,700 shares that will be put to me on monday is $3.71 x 44,700 shares or $165,837.00, plus up front I received $250,320.00 for a total of $416,157.00 - his takeaway is 44,700 x $7.50 or $335,250.00 leaving me with a paper profit of $80,907.00.
In short... he was hoping IPCI would be below $1.90 so as to make a profit, whereas I KNEW it was going to be around $50.00 LOL
I sold 10 of the Jan 5 puts for 2.05.
So you "sold to open"?
Someone sold 45,000 to take out that bid
Well... no stock has been PUT to me yet from the 447 July 2015 $7.50 PUTS I sold... but I know that on Monday morning there will be 44,700 shares of IPCI in my account (they take out $335,250 of cash out).
I don't know how it works on the other end - let's assume it's one individual... does he have the stock and it gets pulled away from him??? does he automatically go short??? does he have to buy 44,700 shares??? I really have no idea what happens on the other end.
Anyway... my average sale was $5.60 - so it's like paying $1.90 for the stock. $3.71 - 1.90 = $1.81 x 44,700 = $80,907 profit (all paper profit of course) - nice little bundle... but peanuts compared to what I expect it to make me going forward.
3 to 5 years - I expect it to be worth over $2 Million.
Yes... and that $1.4 Million last year included a one time bonus payment of $108K - so the downdraft from last year... which included 2-2/3 months exclusivity is less than $100K.
So it seems we can count on almost $5 million (PURE PROFIT - ONLY EXPENSE IS GAS MONEY TO TAKE THE CHECK TO THE BANK) a year from the 5 and 15 alone - hopefully the other 4 strengths bring in an additional $5 million for a total of $10 Million.
No, you're not wrong in your reasoning - but it's far more complex than simply looking at it as that if it really takes off you're screwed - for instance on another stock - and I've done this so it's not theoretical.
I sold $10 PUTS and got a certain amount which was like getting the stock - X amount. I then took that X amount and bought 2X the quantity of the $5 calls - so basically above the $10 where my puts don't gain any more... I make 2x the profit because my calls kick in and I also make a profit between the $5 calls and $10
But when you work with options you need to think in percentages, not dollars
yes bid is 4.40 but that's me at the 4.80 ask - also me that got $5.20 a few days ago - (like getting stock for $2.30) as you see on the last trade - also me sitting on the Jan $5 put for $2.50 - if someone is willing to buy my ask and give me 2.50 I'll take it - like getting ipci for 2.50 now - if it goes to $5 which is the max profit you can make - you'll make 100% - if you buy the stock - it would have to go to $7.00 for you to make 100% - so it's not as simple as saying the most you can make is up to $5 - you need to work %ages -
That's pretty optimistic.
Actually, looking at the whole picture in IPCI options... it's practically non-existent... outside of me and probably the market maker.
For example - I sold 473 of the 520 Jan 16 - $5.00 PUTS - that represents 47,300 IPCI shares, although I don't expect those to be put to me, as I expect we'll be above $5.00 by January
I have sold 450 IPCI July $7.50 puts - so by next friday, someone HAS to buy 45,000 shares of IPCI to deliver to me - not likely they already own it.
come back to us all in spades;)
options ALWAYS expire on the 3rd friday of the month.
They are transacted on saturday and will be posted to your account on monday.